Ketamine-Based Antidepression Nasal Spray Gets FDA Thumbs Up The FDA announced on Tuesday that esketamine has been approved for people with treatment-resistant depression. The drug developed by Janssen Pharmaceuticals Inc. can offer quick relief from symptoms for patients living with the mood disorder. by Diane Samson
Health Doctors Prescribe Low Ketamine Dose To Severe Depression Patients: Experts Question Safety Of Such Practice by Joshua King
Researchers Achieve Record Data Transmission Speed, 4.5 Million Times Faster Than Average Home Broadband